ResearchMoz

ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due to Anti-Bacterial Resistance

GBI Research
Published Date » 2012-01-01
No. Of Pages » 165
   
 GBI Research, the leading business intelligence provider, has released its latest research, “ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due to Anti-Bacterial Resistance”, which provides in-depth analysis of the unmet needs, drivers and barriers that affect the global ENT disorders therapeutics market. The report analyzes the markets for ENT disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan.  
   
 Treatment usage patterns, sales value and annual cost of therapy are forecast until 2017 for key geographies in the five leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers...
Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 ENT Disorders Market - Introduction
2.1 GBI Research Report Guidance

3 ENT Disorders Market - Market Overview
3.1 Rising Global Population and Deteriorating Environmental Conditions Drive ENT Disorder Therapeutics
3.2 Gross Maldistribution
3.3 ENT Disorders Marked By Antibiotic Overuse
3.4 Entry of New Players Restricted by the Number of Generics and Stringent FDA Regulations
3.4.1 Ketolides - A New Class of Antibacterials
3.5 Revenue Forecasts
3.6 Annual Cost of Therapy
3.7 Treatment Usage Patterns
3.7.1 Diseased Population
3.7.2 Treatment Seeking Population
3.7.3 Diagnosed Population
3.7.4 Prescription Population
3.8 Drivers and Restraints of the ENT Disorders Market
3.8.1 ENT Disorders Market Drivers
3.8.2 ENT Disorders Market Restraints

4 ENT Disorders Market - Therapeutic Landscape
4.1 Tonsillitis Market
4.1.1 Introduction
4.1.2 Revenue Forecasts
4.1.3 Annual Cost of Therapy
4.1.4 Treatment Flow Algorithm
4.1.5 Treatment Usage Patterns
4.1.6 Profiles of Key Drugs in the Tonsillitis Market
4.1.7 Geographical Segmentation
4.2 Sinusitis Market
4.2.1 Introduction
4.2.2 Revenue Forecasts
4.2.3 Annual Cost of Therapy
4.2.4 Treatment Flow Algorithm
4.2.5 Treatment Usage Patterns
4.2.6 Profiles of Key Drugs in the Sinusitis Market
4.2.7 Geographical Segmentation
4.3 Rhinitis Market
4.3.1 Introduction
4.3.2 Revenue Forecasts
4.3.3 Annual Cost of Therapy
4.3.4 Treatment Flow Algorithm
4.3.5 Treatment Usage Patterns
4.3.6 Profiles of Key Drugs in the Rhinitis Market
4.3.7 Geographical Segmentation
4.4 Otitis Media Market
4.4.1 Introduction
4.4.2 Revenue Forecasts
4.4.3 Annual Cost of Therapy
4.4.4 Treatment Flow Algorithm
4.4.5 Treatment Usage Patterns
4.4.6 Profiles of Key Drugs in the Otitis Media Market
4.4.7 Geographical Segmentation
4.5 Tracheobronchitis Market
4.5.1 Introduction
4.5.2 Revenue Forecasts
4.5.3 Annual Cost of Therapy
4.5.4 Treatment Flow Algorithm
4.5.5 Treatment Usage Patterns
4.5.6 Profiles of Key Drugs in the Tracheobronchitis Market
4.5.7 Geographical Segmentation

5 ENT Disorders Market - Geographical Landscape
5.1 The US
5.1.1 Revenue Forecasts
5.1.2 Annual Cost of Therapy
5.1.3 Treatment Usage Patterns
5.2 Top Five Countries in Europe
5.2.1 Revenue Forecasts
5.2.2 Annual Cost of Therapy
5.2.3 Treatment Usage Patterns
5.3 Japan
5.3.1 Revenue Forecasts
5.3.2 Annual Cost of Therapy
5.3.3 Treatment Usage Patterns

6 ENT Disorders Market - Pipeline Analysis
6.1 Introduction
6.1.1 Research and Development Pipeline - Tonsillitis
6.1.2 Research and Development Pipeline - Sinusitis
6.1.3 Research and Development Pipeline - Rhinitis
6.1.4 Research and Development Pipeline - Otitis Media

7 ENT Disorders Market - Competitive Landscape
7.1 Competitive Profiling
7.1.1 Abbott Laboratories
7.1.2 Bayer AG
7.1.3 GlaxoSmithKline
7.1.4 Johnson & Johnson (J&J)
7.1.5 Merck & Co
7.1.6 Pfizer
7.1.7 Novartis AG
7.1.8 F. Hoffmann-La Roche Ltd.
7.1.9 Sanofi

8 ENT Disorders Market - Strategic Consolidations
8.1 Overview
8.2 ENT Disorders Market M&A Deals
8.2.1 M&A Deals by Geography
8.2.2 Deals by Type
8.2.3 Major M&A Deals
8.3 R&D Licensing Agreements
8.3.1 Deals by Indication
8.3.2 Deals by Geography
8.3.3 MerLion Pharmaceuticals Enters Into Licensing Agreement with Alcon Pharmaceuticals for Finafloxacin

9 ENT Disorders Market - Appendix
9.1 Market Definitions
9.2 Abbreviations
9.3 Research Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Primary Research
9.3.4 Geographical Landscape
9.3.5 Pipeline Analysis
9.3.6 Competitive Landscape
9.3.7 Expert Panel Validation
9.4 Contact Us
9.5 Disclaimer
9.6 Sources

List of Tables


Table 1: ENT Disorders Market, Global, Revenue ($bn), 2002-2010
Table 2: ENT Disorders Market, Global, Revenue Forecasts ($bn), 2010-2017
Table 3: ENT Disorders Market, Global, Annual Cost of Therapy ($), 2002-2010
Table 4: ENT Disorders Market, Global, Annual Cost of Therapy ($), 2010-2017
Table 5: ENT Disorders Market, Global, Treatment Usage Patterns (million), 2002-2010
Table 6: ENT Disorders Market, Global, Treatment Usage Pattern (million), 2010-2017
Table 7: ENT Disorders Market, Global, Tonsillitis Revenue ($m), 2002-2010
Table 8: ENT Disorders Market, Global, Tonsillitis Revenue Forecasts ($m), 2010-2017
Table 9: ENT Disorders Market, Global, Tonsillitis Annual Cost of Therapy ($), 2002-2010
Table 10: ENT Disorders Market, Global, Tonsillitis Annual Cost of Therapy ($), 2010-2017
Table 11: ENT Disorders Market, Global, Tonsillitis Treatment Usage Patterns (million), 2002-2010
Table 12: ENT Disorders Market, Global, Tonsillitis Treatment Usage Patterns (million), 2010-2017
Table 13: ENT Disorders Market, Global, Tonsillitis, Geographical Segmentation ($m), 2002-2010
Table 14: ENT Disorders Market, Global, Tonsillitis, Geographical Segmentation ($m), 2010-2017
Table 15: ENT Disorders Market, Global, Sinusitis Revenue ($bn), 2002-2010
Table 16: ENT Disorders Market, Global, Sinusitis Revenue Forecasts ($bn), 2010-2017
Table 17: ENT Disorders Market, Global, Sinusitis Annual Cost of Therapy ($), 2002-2010
Table 18: ENT Disorders Market, Global, Sinusitis Annual Cost of Therapy ($), 2010-2017
Table 19: ENT Disorders Market, Global, Sinusitis Treatment Usage Patterns (million), 2002-2010
Table 20: ENT Disorders Market, Global, Sinusitis Treatment Usage Patterns (million), 2010-2017
Table 21: ENT Disorders Market, Global, Sinusitis Market Geographical Segmentation ($m), 2002-2010
Table 22: ENT Disorders Market, Global, Sinusitis Market Geographical Segmentation ($m), 2010-2017
Table 23: ENT Disorders Market, Global, Rhinitis Revenue ($bn), 2002-2010
Table 24: ENT Disorders Market, Global, Rhinitis Revenue Forecasts ($bn), 2010-2017
Table 25: ENT Disorders Market, Global, Rhinitis Annual Cost of Therapy ($), 2002-2010
Table 26: ENT Disorders Market, Global, Rhinitis Annual Cost of Therapy ($), 2010-2017
Table 27: ENT Disorders Market, Global, Rhinitis Treatment Usage Patterns (million), 2002-2010
Table 28: ENT Disorders Market, Global, Rhinitis Treatment Usage Patterns (million), 2010-2017
Table 29: ENT Disorders Market, Global, Rhinitis Market Geographical Segmentation ($m), 2002-2010
Table 30: ENT Disorders Market, Global, Rhinitis Market Geographical Segmentation ($m), 2010-2017
Table 31: ENT Disorders Market, Global, Otitis Media Revenue ($m), 2002-2010
Table 32: ENT Disorders Market, Global, Otitis Media Revenue Forecasts ($m), 2010-2017
Table 33: ENT Disorders Market, Global, Otitis Media Annual Cost of Therapy ($), 2002-2010
Table 34: ENT Disorders Market, Global, Otitis Media Annual Cost of Therapy ($), 2010-2017
Table 35: ENT Disorders Market, Global, Otitis Media Treatment Usage Patterns (million), 2002-2010
Table 36: ENT Disorders Market, Global, Otitis Media Treatment Usage Patterns (million), 2010-2017
Table 37: ENT Disorders Market, Global, Otitis Media Market Geographical Segmentation ($m), 2002-2010
Table 38: ENT Disorders Market, Global, Otitis Media Market Geographical Segmentation ($m), 2010-2017
Table 39: ENT Disorders Market, Global, Tracheobronchitis Revenue ($m), 2002-2010
Table 40: ENT Disorders Market, Global, Tracheobronchitis Revenue Forecasts ($m), 2010-2017
Table 41: ENT Disorders Market, Global, Tracheobronchitis Annual Cost of Therapy ($), 2002-2010
Table 42: ENT Disorders Market, Global, Tracheobronchitis Annual Cost of Therapy ($), 2010-2017
Table 43: ENT Disorders Market, Global, Tracheobronchitis Treatment Usage Patterns (million), 2002-2010
Table 44: ENT Disorders Market, Global, Tracheobronchitis Treatment Usage Patterns (million), 2010-2017
Table 45: ENT Disorders Market, Global, Tracheobronchitis Market Geographical Segmentation ($m), 2002-2010
Table 46: ENT Disorders Market, Global, Tracheobronchitis Market Geographical Segmentation ($m), 2010-2017
Table 47: ENT Disorders Market, Global, Revenue by Geography ($bn), 2002-2010
Table 48: ENT Disorders Market, Global, Revenue Forecasts by Geography ($bn), 2010-2017
Table 49: ENT Disorders Market, The US, Revenue ($bn), 2002-2010
Table 50: ENT Disorders Market, The US, Revenue Forecasts ($bn), 2010-2017
Table 51: ENT Disorders Market, the US, Annual Cost of Therapy ($), 2002-2010
Table 52: ENT Disorders Market, the US, Annual Cost of Therapy ($), 2010-2017
Table 53: ENT Disorders Market, The US, Treatment Usage Pattern (million), 2002-2010
Table 54: ENT Disorders Market, The US, Treatment Usage Patterns (million), 2010-2017
Table 55: ENT Disorders Market, Top Five Countries in Europe, Revenue ($bn), 2002-2010
Table 56: ENT Disorders Market, Top Five Countries in Europe, Revenue Forecasts ($bn), 2010-2017
Table 57: ENT Disorders Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2002-2010
Table 58: ENT Disorders Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2010-2017
Table 59: ENT Disorders Market, Top Five Countries in Europe, Treatment Usage Patterns (million), 2002-2010
Table 60: ENT Disorders Market, Top Five Countries in Europe, Treatment Usage Patterns (million), 2010-2017
Table 61: ENT Disorders Market, Japan, Revenues ($m), 2002-2010
Table 62: ENT Disorders Market, Japan, Revenues ($m), 2010-2017
Table 63: ENT Disorders Market, Japan Annual Cost of Therapy, ($), 2002-2010
Table 64: ENT Disorders Market, Japan Annual Cost of Therapy, ($), 2010-2017
Table 65: ENT Disorders Market, Japan, Treatment Usage Pattern (million), 2002-2010
Table 66: ENT Disorders Market, Japan, Treatment Usage Pattern (million), 2010-2017
Table 67: ENT Disorders Market, Global, Tonsillitis Phase III Clinical Pipeline, 2011
Table 68: ENT Disorders Market, Global, Sinusitis Phase III Clinical Pipeline, 2011
Table 69: ENT Disorders Market, Global, Rhinitis Phase III Clinical Pipeline, 2011
Table 70: ENT Disorders Market, Global, Rhinitis Phase II Clinical Pipeline, 2011
Table 71: ENT Disorders Market, Global, Rhinitis Phase I Clinical Pipeline, 2011
Table 72: ENT Disorders Market, Global, Rhinitis Pre-clinical Pipeline, 2011
Table 73: ENT Disorders Market, Global, Otitis Media, Regulatory Filing and Phase III Clinical Pipeline, 2011

List of Figures


Figure 1: ENT Disorders Market, Global, Revenue Forecasts ($bn), 2002-2017
Figure 2: ENT Disorders Market, Global, Annual Cost of Therapy ($), 2002-2017
Figure 3: ENT Disorders Market, Global, Treatment Usage Patterns (million), 2002-2017
Figure 4: ENT Disorders Market, Global, Diseased Population (million), 2002-2017
Figure 5: ENT Disorders Market, Global, Treatment Seeking Population (million), 2002-2017
Figure 6: ENT Disorders Market, Global, Diagnosis Population (million), 2002-2017
Figure 7: ENT Disorders Market, Global, Prescription Population (million), 2002-2017
Figure 8: ENT Disorders Market, Global, Drivers and Restraints, 2011
Figure 9: ENT Disorders Market, Global, Tonsillitis Revenue Forecasts ($m), 2002-2017
Figure 10: ENT Disorders Market, Global, Tonsillitis Therapeutics Market, Branded and Generic Share, (%), 2010
Figure 11: ENT Disorders Market, Global, Tonsillitis Annual Cost of Therapy ($), 2002-2017
Figure 12: ENT Disorders Market, Global, Tonsillitis, Treatment Flow Algorithm
Figure 13: ENT Disorders Market, Global, Tonsillitis Treatment Usage Patterns (million), 2002-2017
Figure 14: ENT Disorders Market, Global, Tonsillitis Diseased Population (million), 2002-2017
Figure 15: ENT Disorders Market, Global, Tonsillitis Treatment Seeking Population (million), 2002-2017
Figure 16: ENT Disorders Market, Global, Tonsillitis Diagnosis Population (million), 2002-2017
Figure 17: ENT Disorders Market, Global, Tonsillitis Prescription Population (million), 2002-2017
Figure 18: ENT Disorders Market, Global, Tonsillitis Market Segmentation by Geography, (%), 2010 and 2017
Figure 19: ENT Disorders Market, Global, Tonsillitis, Geographical Segmentation ($m), 2002-2017
Figure 20: ENT Disorders Market, Global, Sinusitis Revenue Forecasts ($bn), 2002-2017
Figure 21: ENT Disorders Market, Global, Sinusitis Therapeutics Market, Branded and Generic Share, (%), 2010 and 2017
Figure 22: ENT Disorders Market, Global, Sinusitis Annual Cost of Therapy ($), 2002-2017
Figure 23: ENT Disorders Market, Global, Sinusitis, Treatment Flow Algorithm
Figure 24: ENT Disorders Market, Global, Sinusitis Treatment Usage Patterns (million), 2002-2017
Figure 25: ENT Disorders Market, Global, Sinusitis Diseased Population (million), 2002-2017
Figure 26: ENT Disorders Market, Global, Sinusitis Treatment Seeking Population (million), 2002-2017
Figure 27: ENT Disorders Market, Global, Sinusitis Diagnosed Population (million), 2002-2017
Figure 28: ENT Disorders Market, Global, Sinusitis Prescription Population (million), 2002-2017
Figure 29: ENT Disorders Market, Global, Sinusitis Market Segmentation by Geography, 2010 and 2017
Figure 30: ENT Disorders Market, Global, Sinusitis Market Geographical Segmentation ($bn), 2002-2017
Figure 31: ENT Disorders Market, Global, Rhinitis Revenue Forecasts ($bn), 2002-2017
Figure 32: ENT Disorders Market, Global Rhinitis, Branded and Generic Share, (%), 2010 and 2017
Figure 33: ENT Disorders Market, Global, Rhinitis Annual Cost of Therapy ($), 2002-2017
Figure 34: ENT Disorders Market, Global, Rhinitis, Treatment Flow Algorithm
Figure 35: ENT Disorders Market, Global, Rhinitis Treatment Usage Patterns (million), 2002-2017
Figure 36: ENT Disorders Market, Global, Rhinitis Diseased Population (million), 2002-2017
Figure 37: ENT Disorders Market, Global, Rhinitis Treatment Seeking Population (million), 2002-2017
Figure 38: ENT Disorders Market, Global, Rhinitis Diagnosis Population (million), 2002-2017
Figure 39: ENT Disorders Market, Global, Rhinitis Prescription Population (million), 2002-2017
Figure 40: ENT Disorders Market, Global, Rhinitis Market Segmentation by Geography, 2010 and 2017
Figure 41: ENT Disorders Market, Global, Rhinitis Market Geographical Segmentation ($bn), 2002-2017
Figure 42: ENT Disorders Market, Global, Otitis Media Revenue Forecasts ($m), 2002-2017
Figure 43: ENT Disorders Market, Global, Otitis Media Therapeutics Market, Branded and Generic Share, (%), 2010 and 2017
Figure 44: ENT Disorders Market, Global, Otitis Media Annual Cost of Therapy ($), 2002-2017
Figure 45: ENT Disorders Market, Global, Otitis Media, Treatment Flow Algorithm
Figure 46: ENT Disorders Market, Global, Otitis Media Treatment Usage Patterns (million), 2002-2017
Figure 47: ENT Disorders Market, Global, Otitis Media, Causes (%), 2011
Figure 48: ENT Disorders Market, Global, Otitis Media Diseased Population (million), 2002-2017
Figure 49: ENT Disorders Market, Global, Otitis Media Treatment Seeking Population (million), 2002-2017
Figure 50: ENT Disorders Market, Global, Otitis Media Diagnosed Population (million), 2002-2017
Figure 51: ENT Disorders Market, Global, Otitis Media Prescription Population (million), 2002-2017
Figure 52: ENT Disorders Market, Global, Otitis Media Market Segmentation by Geography, (%), 2010 and 2017
Figure 53: ENT Disorders Market, Global, Otitis Media Market Geographical Segmentation ($m), 2002-2017
Figure 54: ENT Disorders Market, Global, Tracheobronchitis Revenue Forecasts ($m), 2002-2017
Figure 55: ENT Disorders Market , Global, Tracheobronchitis Therapeutics Market, Branded and Generic Share (%), 2010 and 2017
Figure 56: ENT Disorders Market, Global, Tracheobronchitis Annual Cost of Therapy ($), 2002-2017
Figure 57: ENT Disorders Market, Global, Tracheobronchitis, Treatment Flow Algorithm
Figure 58: ENT Disorders Market, Global, Tracheobronchitis Treatment Usage Patterns (million), 2002-2017
Figure 59: ENT Disorders Market, Global, Tracheobronchitis Diseased Population (million), 2002-2017
Figure 60:ENT Disorders Market, Global, Tracheobronchitis Treatment Seeking Population (million), 2002-2017
Figure 61: ENT Disorders Market, Global, Tracheobronchitis Diagnosed Population (million), 2002-2017
Figure 62: ENT Disorders Market, Global, Tracheobronchitis Prescription Population (million), 2002-2017
Figure 63: ENT Disorders Market, Global, Tracheobronchitis Market Segmentation by Geography, 2010 and 2017
Figure 64: ENT Disorders Market, Global, Tracheobronchitis Market Geographical Segmentation ($m), 2002-2017
Figure 65: ENT Disorders Market, Global, Market Share by Geography, (%), 2010 and 2017
Figure 66: ENT Disorders Market, Global, Revenue Forecasts by Geography ($bn), 2002-2017
Figure 67: ENT Disorders Market, The US, Revenue Forecasts ($bn), 2002-2017
Figure 68: ENT Disorders Market, the US, Annual Cost of Therapy ($), 2002-2017
Figure 69: ENT Disorders Market, The US, Treatment Usage Pattern (million), 2002-2017
Figure 70: ENT Disorders Market, The US, Diseased Population (million), 2002-2017
Figure 71: ENT Disorders Market, The US, Treatment Seeking Population (million), 2002-2017
Figure 72: ENT Disorders Market, The US, Diagnosed Population (million), 2002-2017
Figure 73: ENT Disorders Market, The US, Prescription Population (million), 2002-2017
Figure 74: ENT Disorders Market, Top Five Countries in Europe, Revenue Forecasts ($bn), 2002-2017
Figure 75: ENT Disorders Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2002-2017
Figure 76: ENT Disorders Market, Top Five Countries in Europe, Treatment Usage Patterns (million), 2002-2017
Figure 77: ENT Disorders Market, Top Five Countries in Europe, Diseased Population (million), 2002-2017
Figure 78: ENT Disorders Market, Top Five Countries in Europe, Treatment Seeking Population (million), 2002-2017
Figure 79: ENT Disorders Market, Top Five Countries in Europe, Diagnosed Population (million), 2002-2017
Figure 80: ENT Disorders Market, Top Five Countries in Europe, Prescription Population (million), 2002-2017
Figure 81: ENT Disorders Market, Japan, Revenues ($m), 2002-2017
Figure 82: ENT Disorders Market, Japan Annual Cost of Therapy, ($), 2002-2017
Figure 83: ENT Disorders Market, Japan, Treatment Usage Pattern (million), 2002-2017
Figure 84: ENT Disorders Market, Japan, Diseased Population (million), 2002-2017
Figure 85: ENT Disorders Market, Japan, Treatment Seeking Population (million), 2002-2017
Figure 86: ENT Disorders Market, Japan, Diagnosis Population (million), 2002-2017
Figure 87: ENT Disorders Market, Japan, Prescription Population (million), 2002-2017
Figure 88: ENT Disorders Market, Global, R&D Pipeline by Indication (%), 2011
Figure 89: ENT Disorders Market, Global, R&D Pipeline by Phase (%), 2011
Figure 90: ENT Disorders Market, Global, R&D Pipeline by Phase in Sinusitis Market (%), 2011
Figure 91: ENT Disorders Market, Global, R&D Pipeline by Phase in Rhinitis Market (%), 2011
Figure 92: ENT Disorders Market, Global, R&D Pipeline by Phase in Otitis Media (%), 2011
Figure 93: ENT Disorders Market, Global, SWOT - Abbott Laboratories, 2011
Figure 94: ENT Disorders Market, Global, SWOT - Bayer AG, 2011
Figure 95: ENT Disorders Market, Global, SWOT - GSK, 2011
Figure 96: ENT Disorders Market, Global, SWOT - Johnson & Johnson, 2011
Figure 97: ENT Disorders Market, Global, SWOT - Merck, 2011
Figure 98: ENT Disorders Market, Global, SWOT - Pfizer, 2011
Figure 99: ENT Disorders Market, Global, SWOT - Novartis, 2011
Figure 100: ENT Disorders Market, Global, SWOT - Roche, 2011
Figure 101: ENT Disorders Market, Global, SWOT- Sanofi, 2011
Figure 102: ENT Disorders Market, Global, M&A Deals by Indication (%), 2004-2011
Figure 103: ENT Disorders Market, Global, Major M&A Deals By Geography (%), 2004-2011
Figure 104: ENT Disorders Market, Global, Major M&A Deals By Type (%), 2004-2011
Figure 105: ENT Disorders Market, Global, Licensing Deals by Indication (%), 2004-2011
Figure 106: ENT Disorders Market, Global, Licensing Deals By Geography, (%), 2004-2011
Figure 107: GBI Research Market Forecasting Model

Upcoming Reports:

Radiation Detection, Monitoring and Safety Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The escalating use of radiation therapy and nuclear medicine for the purpose of treatment and timely diagnosis of diseases are fueling the growth of the radiation detection market. Some of the key factors which influence the rise of this market are the high occurrence of cancer cases, increased awareness among radiation professionals, and a plethora of technological advancements. Radiation protection, also known as radiological protection, focuses mainly on the protection of people and the environment against the harmful effects of ionizing radiation, which encompasses both...
Healthcare IT Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Healthcare IT is a collective term used for solutions offered by information technology in the healthcare industry. These solutions offer better data management and secure exchange of health information among customers, governments, providers and insurers. There is a huge demand of general applications such as electronic health and medical record system and computerized physician order entry system along with specialized solutions such as clinical trials management system, data mining system and clinical decision support system. Applications such as Picture Archiving and Communication...
Poland: phthaic ahydride market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the phthaic ahydride market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the phthaic ahydride market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Educational Policies Disappoints Most of the Head Teachers
Apr 24, 2015  
As per a research survey of state school leaders in England, many of the head teachers are not convinced by the competing-style of educational policies that are being furnished by one of the political parties which will be held in next month’s general election. The poll will be carried by Ipsos Mori and The Key education consultancy. In which they found that around 58% of the total 1,200...
Cyber Bullying Proving to be a Dreadful Issue
Apr 24, 2015  
On Thursday, Wu Se-hwa, the Minister of Education stated that he would be supporting the legislation against the issues of cyberbullying, if Taiwan is planning to incorporate such laws. Wu Se-hwa was communicating with the reporters for his comments on the death of a actress and model Peng Hsin-yi, more commonly known by her stage-name Cindy, which happened on Tuesday. Peng Hsin-yi...
Education Is a Birth Right and Should Be Made Available Accordingly
Apr 24, 2015  
In the start of the new millennium, the international community has made a commitment for achieving universal primary education for all girls and boys. Currently, which is almost 15 years later, the community thinks that there are still some huge gaps among these commitments and the reality. Across the globe, around 58 million children do not have any access to attend schools,...
British Stocks Fell Flat after Decline in Retail Sales
Apr 23, 2015  
The shares of the top British companies were left mostly unchanged on Thursday, April 23, 2015, after an unforeseen fall in the national retail sales for this month making up for an increase in the utilities shares just 2 weeks before the general election. Whereas the expectation for a single party to win an outright majority on May 7, 2015 is very low, and the experts forecasting a...
Retail Clinics Touched 10 Million Annual Visits
Apr 23, 2015  
The proliferation of retail health means Americans are visiting retail clinics more than 10 million times a year at 1,800-plus locations, yet this convenient and low cost care model accounts for just a fraction of primary care in the U.S. Manatt Health, a health care consulting firm, said retail clinics represent about 2% of “all primary care encounters” in the U.S. even with the...